CLINICAL FLOW CYTOMETRY · TROUBLESHOOTING
Staining, titration and reagents: investigate weak signal without adding more antibody
Educational troubleshooting for laboratory professionals. Apply your validated local SOP; these examples do not establish clinical cut-offs or replace assay validation.
A replacement antibody lot produces a higher negative background and less clear separation. Doubling the volume may intensify the problem. First separate a change in sample, staining conditions, conjugate performance and instrument response.
Keep the comparison interpretable
- Record the clone, fluorochrome, lot, expiry, storage and preparation. Confirm the correct vial and the intended sample type.
- Compare with an appropriate reference sample or retained validated lot where available. Change one factor at a time; different samples stained on different days are a weak lot comparison.
- Review cell input, staining volume, incubation, washing and any fixation against the SOP. A nominal antibody volume is not a transferable concentration across all preparations.
- Investigate the positive population and background separately. Loss of positive signal and rising background are different observations.
- Titrate in the relevant experimental context before approving a change. Assess dim-marker resolution in the complete panel as well as single-colour performance.
A reagent triage map
Several reagents weaken together
Prioritise common factors: sample condition, preparation, acquisition settings and instrument QC.
One reagent changes
Prioritise identity, lot, handling and its control. Confirm that the target population is still present.
A tandem changes both channels
Review conjugate integrity and matched compensation references. A historical matrix may no longer describe the current reagent.
Example: dim CD antigen after a lot switch
Use the same suitable specimen preparation to compare the previous and replacement reagent under controlled conditions. Inspect negative background, positive distribution and separation. Document the acceptance criteria defined by the laboratory before deciding whether the lot is equivalent. A pleasing median fluorescence value alone is not sufficient evidence.
Escalate with evidence
If the issue follows a reagent, retain the raw files, lot details and controlled comparison for supplier investigation. Hold an affected clinical assay according to laboratory policy when its validated acceptance criteria fail.
Compensation and spreading · Sample and instrument checks
Sources
Thermo Fisher: titration and preparation controls · BD: tandem dye and compensation considerations